These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 16546327)
1. SIRT1: tumor promoter or tumor suppressor? Lim CS Med Hypotheses; 2006; 67(2):341-4. PubMed ID: 16546327 [TBL] [Abstract][Full Text] [Related]
2. The enigmatic role of Sir2 in aging. Kennedy BK; Smith ED; Kaeberlein M Cell; 2005 Nov; 123(4):548-50. PubMed ID: 16286003 [TBL] [Abstract][Full Text] [Related]
4. SIRT1 regulates the ribosomal DNA locus: epigenetic candles twinkle longevity in the Christmas tree. Salminen A; Kaarniranta K Biochem Biophys Res Commun; 2009 Jan; 378(1):6-9. PubMed ID: 19010308 [TBL] [Abstract][Full Text] [Related]
6. DBC1 is a negative regulator of SIRT1. Kim JE; Chen J; Lou Z Nature; 2008 Jan; 451(7178):583-6. PubMed ID: 18235501 [TBL] [Abstract][Full Text] [Related]
7. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Ford J; Jiang M; Milner J Cancer Res; 2005 Nov; 65(22):10457-63. PubMed ID: 16288037 [TBL] [Abstract][Full Text] [Related]
9. Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1. Chu F; Chou PM; Zheng X; Mirkin BL; Rebbaa A Cancer Res; 2005 Nov; 65(22):10183-7. PubMed ID: 16288004 [TBL] [Abstract][Full Text] [Related]
10. Sir2 and calorie restriction in yeast: a skeptical perspective. Kaeberlein M; Powers RW Ageing Res Rev; 2007 Aug; 6(2):128-40. PubMed ID: 17512264 [TBL] [Abstract][Full Text] [Related]
11. Diversity in the Sir2 family of protein deacetylases. Buck SW; Gallo CM; Smith JS J Leukoc Biol; 2004 Jun; 75(6):939-50. PubMed ID: 14742637 [TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335 [TBL] [Abstract][Full Text] [Related]
13. Sirtuins (histone deacetylases III) in the cellular response to DNA damage--facts and hypotheses. Kruszewski M; Szumiel I DNA Repair (Amst); 2005 Nov; 4(11):1306-13. PubMed ID: 16084131 [TBL] [Abstract][Full Text] [Related]
15. The critical role of the class III histone deacetylase SIRT1 in cancer. Liu T; Liu PY; Marshall GM Cancer Res; 2009 Mar; 69(5):1702-5. PubMed ID: 19244112 [TBL] [Abstract][Full Text] [Related]
16. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927 [TBL] [Abstract][Full Text] [Related]
17. Human Sir2 and the 'silencing' of p53 activity. Smith J Trends Cell Biol; 2002 Sep; 12(9):404-6. PubMed ID: 12220851 [TBL] [Abstract][Full Text] [Related]
18. Aging and anti-aging: unexpected side effects of everyday medication through sirtuin1 modulation. Engel N; Mahlknecht U Int J Mol Med; 2008 Feb; 21(2):223-32. PubMed ID: 18204789 [TBL] [Abstract][Full Text] [Related]
19. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. Ota H; Akishita M; Eto M; Iijima K; Kaneki M; Ouchi Y J Mol Cell Cardiol; 2007 Nov; 43(5):571-9. PubMed ID: 17916362 [TBL] [Abstract][Full Text] [Related]
20. Comment on "HST2 mediates SIR2-independent life-span extension by calorie restriction". Kaeberlein M; Steffen KK; Hu D; Dang N; Kerr EO; Tsuchiya M; Fields S; Kennedy BK Science; 2006 Jun; 312(5778):1312; author reply 1312. PubMed ID: 16741098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]